Annalisa Jenkins, OBE, MBBS, FRCP.

Chair of the Board

Dr. Annalisa Jenkins, OBE, MBBS, FRCP is a globally recognized biopharma leader with more than 25 years of experience building and financing biotechnology companies. She previously served as President and CEO of Dimension Therapeutics (acquired by Ultragenyx) and held senior leadership roles at Merck Serono and Bristol Myers Squibb. She was appointed an Officer of the Order of the British Empire (OBE) for services to life sciences.